Blog
RSS FeedPosted by Michael Wonder on 10 Jul 2019
Amazon’s Alexa to offer NHS health care advice
10 July 2019 - The UK Government has announced that the NHS has plans to collaborate with Amazon to provide ...
Posted by Michael Wonder on 09 Jul 2019
'Amazing' gene-silencing drugs reach NHS
9 July 2019 - A new form of medicine called "gene-silencing" has been approved for use by the NHS in ...
Posted by Michael Wonder on 09 Jul 2019
NICE Onpattro approval puts Alnylam back in hATTR running
9 July 2019 - NICE has recommended the use of Alynylam’s Onpattro (patisiran), after issuing a preliminary ‘no’, back in ...
Posted by Michael Wonder on 08 Jul 2019
Cystic fibrosis scandal: Drugs boss tells boy, 9, he wants NHS deal to save lives
8 July 2019 - The millionaire boss of a US drugs firm has penned a personal letter to a boy with ...
Posted by Michael Wonder on 08 Jul 2019
NHS England scraps 7 more drugs on prescription
8 July 2019 - NHS England has issued a new guidance scrapping seven medicines from its prescriptions list, estimating to save ...
Posted by Michael Wonder on 08 Jul 2019
AstraZeneca boss calls for NHS drug approval shake-up
5 July 2019 - AstraZeneca has called for a wholesale review of the way new drugs are paid for in ...
Posted by Michael Wonder on 07 Jul 2019
AZ appeals against NICE rejection of Tagrisso in untreated lung cancer
5 July 2019 - AstraZeneca is appealing against NICE’s decision not to recommend funding for its lung cancer drug Tagrisso ...
Posted by Michael Wonder on 05 Jul 2019
Device for preventing and relieving pain of cluster headaches approved by NICE in draft guidance
5 July 2019 - A handheld device that delivers a small electric current has been recommended by NICE for the prevention ...
Posted by Michael Wonder on 05 Jul 2019
Life-extending lung cancer treatment recommended for use on the NHS
5 July 2019 - Dacomitinib has been recommended as a first-line treatment option for people with a type of non-small-cell lung ...
Posted by Michael Wonder on 04 Jul 2019
Spinraza access agreement extended
3 July 2019 - More children with the rare genetic disorder spinal muscular atrophy can now be treated with Spinraza after ...
Posted by Michael Wonder on 02 Jul 2019
Immediately after EU nod, England’s NHS funds Sanofi skin cancer drug
2 July 2019 - Patients in England will be among those who are first to benefit from Sanofi and Regeneron’s ...
Posted by Michael Wonder on 01 Jul 2019
Ethical challenges related to patient involvement in health technology assessment
28 June 2019 - Including information and values from patients in HTA has the potential to improve both the process and ...
Posted by Michael Wonder on 29 Jun 2019
NICE explores extending its use of data to inform its guidance
25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...
Posted by Michael Wonder on 27 Jun 2019
Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements
27 June 2019 - No new government funds committed to no-deal medicines plans. ...
Posted by Michael Wonder on 26 Jun 2019
NICE to make changes to health technology evaluation
26 June 2019 - The Voluntary Scheme for Branded Medicines Pricing and Access, agreed by government and the ABPI in ...